<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180205038630N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-01-16</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>effect of theta binaural beat on primary insomniacs</public_title>
      <acronym></acronym>
      <scientific_title>Study of the efficacy of theta binaural beat on the activity of brain waves in primary insomniacs</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/36419</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Primary insomnia.</hc_freetext>
      <i_freetext>Intervention 1: Experimental group: Binaural beats are generated through Audacity software. The produced Binaural beat is at 6 Hz (theta) frequency. First, it is recorded for 5 minutes with closed eyes of the patient's brain waves through electroencephalography. Then, immediately for 15 minutes, with closed eyes, the theta binaural beat is heard through the headphones by the patient. In the final stage, the brain waves of the patient with closed eyes will be recorded for 5 minutes without receiving the binaural beat. For each patient, only one session is performed, which runs for the first 5 minutes as a pre-test, 15 second, post-test, and the last 5 minutes as follow-up. Intervention 2: Control group: White noise is a signal whose power density is the same at all frequencies. Such a sound will have all the audible frequencies of the same intensity. Therefore, they can be used as a placebo as in the research literature. First, it is recorded for 5 minutes with closed eyes of the patient's brain waves through electroencephalography. Then, immediately for 15 minutes, with closed eyes, the theta binaural beat is heard through the headphones by the patient. In the final stage, the brain waves of the patient with closed eyes will be recorded for 5 minutes without receiving the binaural beat. For each patient, only one session is performed, which runs for the first 5 minutes as a pre-test, 15 second, post-test, and the last 5 minutes as the follow-up.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
IPD collected for the primary outcome measure only,

When:
Start the access period from 1398

To whom:
only available for people working in academic institutions

Conditions:
After qualification, any activity is subject to the observance of ethical standards

Where to obtain:
amirpsy3@gmail.com
Amir Bavafa
+989158018060
Kermanshah, Parastar Blvd, Boostan enghelab dormity

How to obtain:
The request is sent via e-mail and the information is sent within 1 month.
ٍEmail: amirpsy3@gmail.com

Comments:
I have no comments.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amir Bavafa</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Parastar Blvd, boostan enghelab dormity</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9186364357</zip>
        <telephone>+98 83 3836 7333</telephone>
        <email>amirpsy3@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Akbar Foroughi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kermanshah university of medical science., medical school, Parastar Blvd</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9186364357</zip>
        <telephone>+98 83 3837 4371</telephone>
        <email>aliakbar.foroughi@kums.ac.ir</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Informed consent and willingness to participate in research
Evaluation of the index of insomnia severity index (ISI) at the clinical level (Score above 15) In order to enter the clinical interview
Diagnosis of primary insomnia in a clinical interview by a psychiatrist
The absence of severe neurological and psychiatric disorders
Healthy physical and auditory condition
No history of drug abuse
Lack of cardiovascular problems
Non-pregnant female participants
Avoiding alcohol and drugs 12 hours before intervention</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The annoying nature of the music used
The occurrence of any physical and psychological warning signs such as headache
Unwillingness to continue protocol of intervention by the patient
Many artifacts during brain wave recordings, such as shaking or talking</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F51.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Insomnia not due to a substance or known physiological condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Experimental group: Binaural beats are generated through Audacity software. The produced Binaural beat is at 6 Hz (theta) frequency. First, it is recorded for 5 minutes with closed eyes of the patient's brain waves through electroencephalography. Then, immediately for 15 minutes, with closed eyes, the theta binaural beat is heard through the headphones by the patient. In the final stage, the brain waves of the patient with closed eyes will be recorded for 5 minutes without receiving the binaural beat. For each patient, only one session is performed, which runs for the first 5 minutes as a pre-test, 15 second, post-test, and the last 5 minutes as follow-up.</i_keyword>
      <i_keyword>Control group: White noise is a signal whose power density is the same at all frequencies. Such a sound will have all the audible frequencies of the same intensity. Therefore, they can be used as a placebo as in the research literature. First, it is recorded for 5 minutes with closed eyes of the patient's brain waves through electroencephalography. Then, immediately for 15 minutes, with closed eyes, the theta binaural beat is heard through the headphones by the patient. In the final stage, the brain waves of the patient with closed eyes will be recorded for 5 minutes without receiving the binaural beat. For each patient, only one session is performed, which runs for the first 5 minutes as a pre-test, 15 second, post-test, and the last 5 minutes as the follow-up.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Brain wave pattern. Timepoint: Within 5 minutes before the intervention, 15 minutes during the intervention and 5 minutes later. Method of measurement: Electroencephalography (EEG).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-12-26</approval_date>
        <contact_name>Ethics Committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Parastar Blvd, faculty of medicine Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
